What Are the Clinical Factors Associated With a Significant Pain Reduction Following Physiotherapy in Patients With Temporomandibular Disorders?
Predictors of Good Outcomes Following Manual Therapy in Patients With Temporomandibular Disorders: Development and Validation Studies
1 other identifier
observational
180
1 country
1
Brief Summary
RATIONALE OF THE OBSERVATION STUDY: This study aims to observe which patients with temporomandibular disorder improve more following a physiotherapy program of four sessions. Knowing the characteristics of patients who have the most significant improvements could help clinician advise or advise against physiotherapy for the treatment of temporomandibular disorders. STUDY PROCEDURES The study will be conducted at the Istituto Stomatologico Italiano. Patients diagnosed with Temporomandibular Disorder will be recruited in the gnathological and neuromuscular gnathological departments. The physiotherapists of the Craniomandibular Physiotherapy Service will perform physiotherapy therapy, which consists of four physiotherapy sessions \[lasting 30 minutes, about once a week\] over a month. Before starting the treatment, participants will be asked to answer some questions concerning their state of health (e.g. pain intensity) with particular reference to Temporomandibular Disorder (e.g. location and duration of pain). The intensity of pain and the level of function will then be monitored at baseline, after 4 weeks and after 8 weeks from baseline. EXPECTED BENEFITS FROM THE STUDY AND EXPECTED BENEFITS FOR THE PATIENT The benefits are the discovery of new knowledge in the field of therapeutic choice for patients with temporomandibular disorder.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 14, 2019
CompletedFirst Submitted
Initial submission to the registry
June 17, 2019
CompletedFirst Posted
Study publicly available on registry
June 19, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2025
CompletedMay 14, 2025
May 1, 2025
5.6 years
June 17, 2019
May 9, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Change in Pain Intensity (Visual Analogue Scale [VAS]) from baseline to one month
Pain intensity will be calculated by averaging the ratings of current pain, average pain in the past week, and worst pain in the past week using the Visual Analogue Scale (VAS), consisting of a horizontal line measuring 10 cm (without marks), with "no pain" written at the left extremity, and "worst pain imaginable" at the right extremity. Patients will be educated to trace a perpendicular line on the horizontal line to intend the pain intensity. The distance from the 0 points will be after measured in millimetres. The VAS is a reliable and valid scale to assess pain intensity as an outcome measure in intervention studies. Based on the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) recommendations about TMD , a reduction of at least 30% of the VAS score for pain intensity is considered clinically significant. Consequently, a reduction in the total VAS score \[≥ 30%\] will be defined as a good outcome
Change from baseline to one month
Change in Pain Intensity (Visual Analogue Scale [VAS]) from baseline to two month
Pain intensity will be calculated by averaging the ratings of current pain, average pain in the past week, and worst pain in the past week using the Visual Analogue Scale (VAS), consisting of a horizontal line measuring 10 cm (without marks), with "no pain" written at the left extremity, and "worst pain imaginable" at the right extremity. Patients will be educated to trace a perpendicular line on the horizontal line to intend the pain intensity. The distance from the 0 points will be after measured in millimetres. The VAS is a reliable and valid scale to assess pain intensity as an outcome measure in intervention studies. Based on the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) recommendations about TMD , a reduction of at least 30% of the VAS score for pain intensity is considered clinically significant. Consequently, a reduction in the total VAS score \[≥ 30%\] will be defined as a good outcome
Change from baseline to two month
Change in Function (patient specific functional scale [PSFS]) from baseline to one month
To capture a potential change in function, patients will also complete the patient specific functional scale (PSFS). The PSFS is a self reported outcome measure assessing functional change in patients with musculoskeletal disorders. It is responsive to clinically significant change over time, even in chronic pain patients. Patients are invited to rate, on an 11-point scale, their level of difficulty performing at least three different daily activities. Following the treatment, patients are required to score again the activities previously rated. It is known the PSFS is a valid, reliable, and responsive outcome measure with a high test-retest reliability in patients with lower back pain and knee problems.
Change from baseline to one month
Change in Function (patient specific functional scale [PSFS]) from baseline to two month
To capture a potential change in function, patients will also complete the patient specific functional scale (PSFS). The PSFS is a self reported outcome measure assessing functional change in patients with musculoskeletal disorders. It is responsive to clinically significant change over time, even in chronic pain patients. Patients are invited to rate, on an 11-point scale, their level of difficulty performing at least three different daily activities. Following the treatment, patients are required to score again the activities previously rated. It is known the PSFS is a valid, reliable, and responsive outcome measure with a high test-retest reliability in patients with lower back pain and knee problems.
Change from baseline to two month
Other Outcomes (6)
Pain during maximal mouth opening
Baseline, one month, two months
Central sensitisation: Central Sensitisation Inventory (CSI)
Baseline
Treatment expectations
Baseline
- +3 more other outcomes
Study Arms (1)
TMD
Patients (aged ≥18 years) with a diagnosis of Temporomandibular Disorders
Interventions
Participants will receive four sessions of manual therapy applied to craniomandibular structures over four weeks. The application of manual therapy aims to decrease pain by treating masticatory muscle trigger points, muscle tightness, and restricted temporomandibular joint movements. Several techniques will be considered, including ventral and caudal anterior glide temporomandibular joint mobilisation, soft tissue interventions for the management of trigger points in masticatory muscles and myofascial induction therapy applied to craniomandibular structures. The structures targeted in the treatment sessions will be the temporomandibular joint, temporal muscles, masseter muscles, medial and lateral pterygoid muscles and suprahyoid muscles.
Eligibility Criteria
Patients will be recruited in a Dental Hospital \[TMJ Unit\].
You may qualify if:
- (1) adults aged ≥18 years;
- (2) TMD diagnosis according to the Axis I of the Diagnostic Criteria for TMDs (DC/TMD) (Shiffman et al., 2014);
- (3) no therapeutic interventions reported (for their TMD) in the past six months (Wahlund et al., 2015);
- (4) capacity to use and understand written and verbal Italian language;
- (5) mental capacity to provide informed consent.
You may not qualify if:
- (1) TMD pain related to rheumatoid/inflammatory arthritis;
- (2) any physical or mental condition that could potentially influence the study;
- (3) they commence another treatment for their TMD (pharmacology, oral appliance, others) throughout the duration of the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Istituto Stomatologico Italianolead
- University of Birminghamcollaborator
Study Sites (1)
Istituto Stomatologico Italiano
Miano, Milano, 20122, Italy
Related Publications (5)
Asquini G, Devecchi V, Borromeo G, Tessera P, Russillo A, Michelotti A, Bucci R, Falla D. External Validation of a Clinical Prediction Tool for the Use of Manual Therapy in Patients With Temporomandibular Disorders. J Oral Rehabil. 2026 Feb;53(2):515-528. doi: 10.1111/joor.70092. Epub 2025 Nov 11.
PMID: 41216702DERIVEDAsquini G, Devecchi V, Edoardo Bianchi A, Borromeo G, Tessera P, Falla D. External validation of a clinical prediction tool for the use of manual therapy for patients with temporomandibular disorders: a protocol for a prospective observational study. BMJ Open. 2023 Jul 14;13(7):e069327. doi: 10.1136/bmjopen-2022-069327.
PMID: 37451727DERIVEDAsquini G, Devecchi V, Borromeo G, Viscuso D, Morato F, Locatelli M, Falla D. Predictors of pain reduction following a program of manual therapies for patients with temporomandibular disorders: A prospective observational study. Musculoskelet Sci Pract. 2022 Dec;62:102634. doi: 10.1016/j.msksp.2022.102634. Epub 2022 Jul 31.
PMID: 35939919DERIVEDAsquini G, Bianchi AE, Borromeo G, Locatelli M, Falla D. The impact of Covid-19-related distress on general health, oral behaviour, psychosocial features, disability and pain intensity in a cohort of Italian patients with temporomandibular disorders. PLoS One. 2021 Feb 2;16(2):e0245999. doi: 10.1371/journal.pone.0245999. eCollection 2021.
PMID: 33529226DERIVEDAsquini G, Bianchi AE, Heneghan NR, Rushton AB, Borromeo G, Locatelli M, Falla D. Predictors of pain reduction following manual therapy in patients with temporomandibular disorders: a protocol for a prospective observational study. BMJ Open. 2019 Nov 12;9(11):e032113. doi: 10.1136/bmjopen-2019-032113.
PMID: 31722951DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Giacomo Asquini
Istituto Stomatologico Italiano
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Physiotherapist at the Italian Stomatologic Institute - Craniomandibular Physiotherapy Service
Study Record Dates
First Submitted
June 17, 2019
First Posted
June 19, 2019
Study Start
June 14, 2019
Primary Completion
January 1, 2025
Study Completion
January 1, 2025
Last Updated
May 14, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share